产品证据图
每个产品都有一个集中的源集。
搜索和过滤
证据记录
按产品、年份或研究模型缩小记录范围。打开每个源以检查其结果和局限性。
烟酰胺 N-甲基转移酶的选择性膜渗透性小分子抑制剂可逆转高脂饮食诱导的小鼠肥胖
Neelakantan H 等。《生物化学药理学》。2018;147:141–152。PMID 29155147 · DOI 10.1016/j.bcp.2017.11.007
烟酰胺N-甲基转移酶小分子抑制剂
《J. Med. Chem.》2017年。PMID 28548833 · DOI 10.1021/acs.jmedchem.7b00389。.
Tirzepatide for Obesity Treatment and Diabetes Prevention.
Tirzepatide for Obesity Treatment and Diabetes Prevention.
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.
Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction.
Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction.
Peptide Isolation – Method Development Considerations
Peptide Isolation – Method Development Considerations
Humanin peptide suppresses apoptosis by interfering with Bax activation
Humanin peptide suppresses apoptosis by interfering with Bax activation
Humanin induces conformational changes in the apoptosis regulator BAX and sequesters it into fibers, preventing mitochondrial outer-membrane permeabilization
Humanin induces conformational changes in the apoptosis regulator BAX and sequesters it into fibers, preventing mitochondrial outer-membrane permeabilization
Enhanced Endosomal Signaling and Desensitization of GLP-1R vs GIPR in Pancreatic Beta Cells
Enhanced Endosomal Signaling and Desensitization of GLP-1R vs GIPR in Pancreatic Beta Cells
Receptor Binding Assays for HTS and Drug Discovery
Receptor Binding Assays for HTS and Drug Discovery
编辑方法
记录如何分类
记录按来源 URL 进行重复数据删除，并链接到每个相关产品系列。研究类型和模型是从引文和编辑证据标签推断出来的，然后在内容 QA 期间进行审查。
支持监管状态、配方或化学特性的标签和数据库。
对照试验、系统评价和其他具有特定人群解释的临床记录。
无法确定人类结果的动物、细胞、分析和机械记录。
叙述性评论、登记和申办者报告与同行评审的结果明显不同。